Figure 4 | Scientific Reports

Figure 4

From: A new clinical-genomic model to predict 10-year recurrence risk in primary operable breast cancer patients

Figure 4

Consolidated Standards of Reporting Trials for this study. Using LASSO to select significant genes. Abbreviation: IHC: immunohistochemistry; DGM: Distant genomic model; CM6: Clinical model 6 (age, lymphovascular invasion, oestrogen receptor, lymph node status, tumor size and grade); ROR: risk of recurrence; LASSO: Least Absolute Shrinkage and Selection Operator.

Back to article page